Logo image of ESIGM.MI

ESI SPA (ESIGM.MI) Stock Fundamental Analysis

Europe - BIT:ESIGM - IT0005421885 - Common Stock

1.74 EUR
-0.01 (-0.57%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ESIGM. ESIGM was compared to 41 industry peers in the Construction & Engineering industry. ESIGM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ESIGM is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ESIGM had positive earnings in the past year.
In the past year ESIGM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ESIGM reported negative net income in multiple years.
In multiple years ESIGM reported negative operating cash flow during the last 5 years.
ESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.56%, ESIGM is doing worse than 78.57% of the companies in the same industry.
With a Return On Equity value of 3.90%, ESIGM is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
ESIGM's Return On Invested Capital of 5.74% is in line compared to the rest of the industry. ESIGM outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 3.9%
ROIC 5.74%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ESIGM.MI Yearly ROA, ROE, ROICESIGM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a Profit Margin value of 0.48%, ESIGM is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
ESIGM's Profit Margin has declined in the last couple of years.
ESIGM has a worse Operating Margin (1.60%) than 80.95% of its industry peers.
ESIGM's Operating Margin has improved in the last couple of years.
The Gross Margin of ESIGM (12.68%) is worse than 83.33% of its industry peers.
ESIGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.6%
PM (TTM) 0.48%
GM 12.68%
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
ESIGM.MI Yearly Profit, Operating, Gross MarginsESIGM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 100 150

4

2. Health

2.1 Basic Checks

ESIGM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ESIGM has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ESIGM has been reduced compared to a year ago.
ESIGM.MI Yearly Shares OutstandingESIGM.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ESIGM.MI Yearly Total Debt VS Total AssetsESIGM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that ESIGM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ESIGM (1.78) is comparable to the rest of the industry.
ESIGM has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as ESIGM would need 2.43 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.43, ESIGM is doing good in the industry, outperforming 71.43% of the companies in the same industry.
ESIGM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.28, ESIGM is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Altman-Z 1.78
ROIC/WACC0.76
WACC7.54%
ESIGM.MI Yearly LT Debt VS Equity VS FCFESIGM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ESIGM has a Current Ratio of 1.13. This is a normal value and indicates that ESIGM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ESIGM (1.13) is comparable to the rest of the industry.
ESIGM has a Quick Ratio of 1.13. This is a bad value and indicates that ESIGM is not financially healthy enough and could expect problems in meeting its short term obligations.
ESIGM's Quick ratio of 0.26 is on the low side compared to the rest of the industry. ESIGM is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.26
ESIGM.MI Yearly Current Assets VS Current LiabilitesESIGM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

7

3. Growth

3.1 Past

ESIGM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 213.12%, which is quite impressive.
The Earnings Per Share has been growing by 115.72% on average over the past years. This is a very strong growth
The Revenue for ESIGM has decreased by -14.49% in the past year. This is quite bad
ESIGM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 146.66% yearly.
EPS 1Y (TTM)213.12%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%281.46%
Revenue 1Y (TTM)-14.49%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-11.31%

3.2 Future

Based on estimates for the next years, ESIGM will show a decrease in Earnings Per Share. The EPS will decrease by -2.61% on average per year.
The Revenue is expected to grow by 22.71% on average over the next years. This is a very strong growth
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ESIGM.MI Yearly Revenue VS EstimatesESIGM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ESIGM.MI Yearly EPS VS EstimatesESIGM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

ESIGM is valuated cheaply with a Price/Earnings ratio of 6.69.
Based on the Price/Earnings ratio, ESIGM is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ESIGM to the average of the S&P500 Index (27.27), we can say ESIGM is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 4.80, the valuation of ESIGM can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ESIGM indicates a rather cheap valuation: ESIGM is cheaper than 97.62% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ESIGM to the average of the S&P500 Index (22.77), we can say ESIGM is valued rather cheaply.
Industry RankSector Rank
PE 6.69
Fwd PE 4.8
ESIGM.MI Price Earnings VS Forward Price EarningsESIGM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESIGM is valued a bit more expensive than the industry average as 69.05% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, ESIGM is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.38
EV/EBITDA 17.16
ESIGM.MI Per share dataESIGM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as ESIGM's earnings are expected to decrease with -2.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ESIGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ESI SPA

BIT:ESIGM (9/5/2025, 7:00:00 PM)

1.74

-0.01 (-0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.10M
Analysts84.44
Price Target2.55 (46.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.69
Fwd PE 4.8
P/S 0.44
P/FCF 22.38
P/OCF 18.13
P/B 3.56
P/tB 4.35
EV/EBITDA 17.16
EPS(TTM)0.26
EY14.94%
EPS(NY)0.36
Fwd EY20.84%
FCF(TTM)0.08
FCFY4.47%
OCF(TTM)0.1
OCFY5.52%
SpS3.98
BVpS0.49
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 3.9%
ROCE 9.47%
ROIC 5.74%
ROICexc 9.37%
ROICexgc 11.87%
OM 1.6%
PM (TTM) 0.48%
GM 12.68%
FCFM 1.95%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y168.74%
ROICexcg growth 5YN/A
ROICexc growth 3Y186.11%
ROICexc growth 5YN/A
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Debt/EBITDA 1.42
Cap/Depr 55.73%
Cap/Sales 0.46%
Interest Coverage 250
Cash Conversion 99.74%
Profit Quality 408.23%
Current Ratio 1.13
Quick Ratio 0.26
Altman-Z 1.78
F-Score6
WACC7.54%
ROIC/WACC0.76
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)213.12%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%281.46%
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.49%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-11.31%
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y140.4%
EBIT growth 3Y198.75%
EBIT growth 5YN/A
EBIT Next Year13.94%
EBIT Next 3Y15.12%
EBIT Next 5YN/A
FCF growth 1Y91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.91%
OCF growth 3YN/A
OCF growth 5YN/A